RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Immunoglobulin A Vasculitis: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Authors' reply to the Letter to the Editor by Dotis J: Pediatric IgA vasculitis nephritis: Japanese guidance in the context of IPNA and KDIGO recommendations.
Shimizu Masaki et al., Clinical and experimental nephrology (17 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42891899/
- 2.
DIAGNOSTICO MULTIDISCIPLINAR E ESTRATEGIAS NO TRATAMENTO DA PURPURA DE HENOCH-SCHÖNLEIN NA INFANCIA
Brayan Yamid Bohorquez Beltran et al., Veredas do Direito Direito Ambiental e Desenvolvimento Sustentável (16 October 2026)
https://doi.org/10.18623/rvd.v23.8636
- 3.
Genome-wide studies define genetic mechanisms of IgA vasculitis
Lili Liu et al., Nature Communications (15 October 2026)
https://doi.org/10.1038/s41467-026-78026-6
- 4.
Coagulation and fibrinolysis biomarkers associated with gastrointestinal bleeding in children with immunoglobulin A vasculitis: a retrospective cohort study
Fang Chen et al., Frontiers in Pediatrics (14 October 2026)
https://doi.org/10.3389/fped.2026.1886693
- 5.
Clinical and laboratory parameters associated with renal involvement in childhood IgA vasculitis: a prospective cohort study
Buket Esen Ağar et al., BMC Pediatrics (13 October 2026)
https://doi.org/10.1186/s12887-026-07809-z
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Immunoglobulin A Vasculitis
Immunoglobulin A vasculitis is a condition in which small blood vessels become inflamed, most often in children. It typically causes a rash of small bruise-like spots, joint pain, tummy pain and sometimes kidney involvement. Many people recover on their own with rest and pain relief, while more serious cases may need medicines to calm the immune system.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Immunoglobulin A Vasculitis?
Immunoglobulin A vasculitis is a condition in which small blood vessels become inflamed, most often in children. It typically causes a rash of small bruise-like spots, joint pain, tummy pain and sometimes kidney involvement. Many people recover on their own with rest and pain relief, while more serious cases may need medicines to calm the immune system.
How many clinical trials are available for Immunoglobulin A Vasculitis?
RareWays currently indexes 12 clinical trials for Immunoglobulin A Vasculitis, of which 5 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Immunoglobulin A Vasculitis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Immunoglobulin A Vasculitis.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.